{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T11:43:01Z","timestamp":1773661381445,"version":"3.50.1"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["IP 2015 022074"],"award-info":[{"award-number":["IP 2015 022074"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Stem Cell Research"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.scr.2021.102239","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T13:29:50Z","timestamp":1613050190000},"page":"102239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Medical progress: Stem cells as a new therapeutic strategy for COVID-19"],"prefix":"10.1016","volume":"52","author":[{"given":"Claudia","family":"Musial","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Gorska-Ponikowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.scr.2021.102239_b0005","unstructured":"Cascella, M., Rajnik, M., Cuomo, A., 2020. eFeatures, Evaluation, and Treatment of Coronavirus. [Updated 2020 Oct 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554776\/ (20\/11\/2020)."},{"issue":"5","key":"10.1016\/j.scr.2021.102239_b0010","doi-asserted-by":"crossref","first-page":"105951","DOI":"10.1016\/j.ijantimicag.2020.105951","article-title":"Coronavirus disease 2019 (COVID-19): current status and future perspectives","volume":"55","author":"Li","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.scr.2021.102239_b0015","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.scr.2021.102239_b0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.scr.2021.102239_b0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.scr.2021.102239_b0030","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.scr.2021.102239_b0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.scr.2021.102239_b0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.scr.2021.102239_b0045","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Resp. Med."},{"issue":"9","key":"10.1016\/j.scr.2021.102239_b0050","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/nsr\/nwaa123","article-title":"Autopsy of COVID-19 victims in China","volume":"7","author":"Bian","year":"2020","journal-title":"Nat. Sci. Rev."},{"issue":"7","key":"10.1016\/j.scr.2021.102239_b0055","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Internal Med."},{"key":"10.1016\/j.scr.2021.102239_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","volume":"5","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discovery"},{"key":"10.1016\/j.scr.2021.102239_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.scr.2021.102239_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.scr.2021.102239_b0075","unstructured":"Coronavirus 2019\u2010nCoV, 2020. CSSE. Coronavirus 2019\u2010nCoV Global Cases by Johns Hopkins CSSE. Available online: https:\/\/www.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6 (22\/11\/2020)."},{"issue":"4","key":"10.1016\/j.scr.2021.102239_b0080","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.scr.2021.102239_b0085","first-page":"1101","article-title":"Clinical characteristics of 2019 novel coronavirus infection in China","volume":"10","author":"Guan","year":"2020","journal-title":"medRxiv preprint posted online"},{"issue":"3","key":"10.1016\/j.scr.2021.102239_b0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.scr.2021.102239_b0095","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.scr.2021.102239_b0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.scr.2021.102239_b0105","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41591-018-0036-4","article-title":"Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells","volume":"24","author":"Norelli","year":"2018","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.scr.2021.102239_b0110","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.stem.2018.05.013","article-title":"Regenerating eye tissues to preserve and restore vision","volume":"22","author":"Stern","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.46582\/jsrm.1401003","article-title":"Re-defining stem cell-cardiomyocyte interactions: focusing on the paracrine effector approach","volume":"14","author":"Mahapatra","year":"2018","journal-title":"J. Stem Cells Regenerat. Med."},{"key":"10.1016\/j.scr.2021.102239_b0120","first-page":"8086269","article-title":"Limbal stem cell transplantation: clinical results, limits, and perspectives","author":"Sacchetti","year":"2018","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0125","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12967-016-1101-8","article-title":"Repressed SIRT1\/PGC-1\u03b1 pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration","volume":"14","author":"Golestaneh","year":"2016","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0130","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.453","article-title":"Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration","volume":"8","author":"Golestaneh","year":"2017","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.scr.2021.102239_b0135","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/cells9030563","article-title":"Recent progress of stem cell therapy in cancer treatment: molecular mechanisms and potential applications","volume":"9","author":"Chu","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.scr.2021.102239_b0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fimmu.2017.00339","article-title":"Antimicrobial activity of mesenchymal stem cells: current status and new perspectives of antimicrobial peptide-based therapies","volume":"8","author":"Alcayaga-Miranda","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.scr.2021.102239_b0145","unstructured":"Chen, S., 2020. Coronavirus: critically ill Chinese patient saved by stem cell therapy, study says. South China Morning Post, March 2, 2020. Accessed date 3\/18\/2020."},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-018-0774-8","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model","volume":"9","author":"Khatri","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"15","key":"10.1016\/j.scr.2021.102239_b0155","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1089\/scd.2010.0566","article-title":"Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats","volume":"21","author":"Waszak","year":"2012","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13287-016-0395-z","article-title":"Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice","volume":"7","author":"Li","year":"2016","journal-title":"Stem Cell Res. Ther."},{"issue":"13","key":"10.1016\/j.scr.2021.102239_b0165","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1073\/pnas.1601911113","article-title":"Human mesenchymal stromal cells reduce influenza a H5N1-associated acute lung injury in vitro and in vivo","volume":"113","author":"Chan","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.scr.2021.102239_b0170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/CCM.0000000000002073","article-title":"Cryopreserved, xeno-free human umbilical cord mesenchymal stromal cells reduce lung injury severity and bacterial burden in rodent Escherichia coli\u2013induced acute respiratory distress syndrome","volume":"45","author":"Curley","year":"2017","journal-title":"Crit. Care Med."},{"issue":"6","key":"10.1016\/j.scr.2021.102239_b0175","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/stem.643","article-title":"Concise review: mesenchymal stem cells for acute lung injury: role of paracrine soluble factors","volume":"29","author":"Lee","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.scr.2021.102239_b0180","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by mesenchymal stem cells (MSCs): mechanisms of action of living, apoptotic, and dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.scr.2021.102239_b0185","first-page":"1939768","article-title":"Therapeutic potential of mesenchymal stem cells and their secretome in the treatment of SARS-CoV-2-induced acute respiratory distress syndrome","volume":"20","author":"Harrell","year":"2020","journal-title":"Anal Cell Pathol. (Amst)."},{"key":"10.1016\/j.scr.2021.102239_b0190","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.scr.2021.102239_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.scr.2021.102239_b0200","article-title":"Mesenchymal stem cells: a new front emerge in COVID19 treatment: mesenchymal Stem Cells therapy for SARS-CoV2 viral infection","author":"Raza","year":"2020","journal-title":"Cytotherapy"},{"issue":"12","key":"10.1016\/j.scr.2021.102239_b0205","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-08311-4","article-title":"Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.scr.2021.102239_b0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/sctm.19-0092","article-title":"Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells","volume":"9","author":"Chow","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.scr.2021.102239_b0220","doi-asserted-by":"crossref","first-page":"5303048","DOI":"10.1155\/2016\/5303048","article-title":"Antimicrobial properties of mesenchymal stem cells: Therapeutic potential for cystic fibrosis infection, and treatment","author":"Sutton","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.scr.2021.102239_b0225","first-page":"3169469","article-title":"Mesenchymal stem cells enhance pulmonary antimicrobial immunity and prevent following bacterial infection","author":"Li","year":"2020","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.scr.2021.102239_b0230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-94-007-4798-2_8","article-title":"Role of mesenchymal stem cells (MSC) in HIV-1 associated bone and lipid toxicities","volume":"8","author":"Cotter","year":"2012","journal-title":"Stem Cells Cancer Stem Cells"},{"issue":"17","key":"10.1016\/j.scr.2021.102239_b0235","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/eurheartj\/ehq467","article-title":"Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis","volume":"32","author":"Van Linthout","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.scr.2021.102239_b0240","first-page":"860950","article-title":"Mesenchymal stromal cells and viral infection","author":"Thanunchai","year":"2015","journal-title":"Stem Cells Int."},{"issue":"3","key":"10.1016\/j.scr.2021.102239_b0245","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cell.2017.11.018","article-title":"Intrinsic immunity shapes viral resistance of stem cells","volume":"172","author":"Wu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.scr.2021.102239_b0250","unstructured":"ClinicalTrials.gov, 2020. Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With 2019 Novel Coronavirus. Identifier: NCT04252118, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04252118 (21\/11\/2020)."},{"key":"10.1016\/j.scr.2021.102239_b0255","first-page":"4236973","article-title":"Mesenchymal stem cell-based therapy of inflammatory lung diseases: current understanding and future perspectives","author":"Harrell","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.scr.2021.102239_b0260","first-page":"1474","article-title":"Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study","author":"Connick","year":"2012","journal-title":"Electronic"},{"key":"10.1016\/j.scr.2021.102239_b0265","unstructured":"Wilson J.G., Liu K.D., Zhuo H., Caballero L., McMillan M., Fang X., 2014. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. (2213\u20132619 (Electronic))."},{"key":"10.1016\/j.scr.2021.102239_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13578-020-00433-z","article-title":"Perspective of placenta derived mesenchymal stem cells in acute liver failure","volume":"10","author":"Saleh","year":"2020","journal-title":"Cell Biosci."},{"issue":"8","key":"10.1016\/j.scr.2021.102239_b0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/01902148.2013.816803","article-title":"Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell","volume":"39","author":"Inamdar","year":"2013","journal-title":"Exp. Lung. Res."},{"key":"10.1016\/j.scr.2021.102239_b0280","doi-asserted-by":"crossref","unstructured":"Walter J., Ware L.B., Matthay M.A., 2014. Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. (2213\u20132619 (Electronic)).","DOI":"10.1016\/S2213-2600(14)70217-6"},{"issue":"23","key":"10.1016\/j.scr.2021.102239_b0285","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1242\/jcs.01488","article-title":"In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions","volume":"117","author":"Anjos-Afonso","year":"2004","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.scr.2021.102239_b0290","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14336\/AD.2020.0301","article-title":"Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)-induced pneumonia","volume":"11","author":"Shetty","year":"2020","journal-title":"Aging Dis."},{"issue":"31","key":"10.1016\/j.scr.2021.102239_b0295","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021429","article-title":"Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: a case report","volume":"99","author":"Liang","year":"2020","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.scr.2021.102239_b0300","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.scr.2021.102239_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104422","article-title":"The role of extracellular vesicles in COVID-19 virus infection","volume":"85","author":"Hassanpour","year":"2020","journal-title":"Infection, Genetics Evolution"},{"key":"10.1016\/j.scr.2021.102239_b0310","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s13287-020-01866-6","article-title":"Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia","volume":"11","author":"Akbari","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.scr.2021.102239_b0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41232-020-00121-y","article-title":"Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases","volume":"40","author":"Tsuchiya","year":"2020","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.scr.2021.102239_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100454","article-title":"Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study","volume":"25","author":"S\u00e1nchez-Guijo","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.scr.2021.102239_b0325","article-title":"Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment","author":"Chen","year":"2020","journal-title":"Engineering (Beijing, China)"},{"key":"10.1016\/j.scr.2021.102239_b0330","first-page":"41","article-title":"Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection","volume":"15","author":"Foronjy","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.scr.2021.102239_b0335","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5772\/60622","article-title":"Multiple sclerosis and the LIF\/IL-6 axis: use of nanotechnology to harness the tolerogenic and reparative properties of LIF","volume":"2","author":"Metcalfe","year":"2015","journal-title":"Nanobiomedicine"},{"key":"10.1016\/j.scr.2021.102239_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100019","article-title":"Mesenchymal stem cells and management of COVID-19 pneumonia","volume":"5","author":"Metcalfe","year":"2020","journal-title":"Med Drug Discovery"},{"key":"10.1016\/j.scr.2021.102239_b0345","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s13287-020-01875-5","article-title":"Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells","volume":"11","author":"Shu","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.scr.2021.102239_b0350","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.14336\/AD.2020.0608","article-title":"Stem cell based therapy option in COVID-19: is it really promising?","volume":"11","author":"Irmak","year":"2020","journal-title":"Aging Disease"},{"key":"10.1016\/j.scr.2021.102239_b0355","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.scr.2021.102239_b0360","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.afos.2018.11.083","article-title":"The advantages and limitations of mesenchymal stem cells in clinical application for treating human diseases","volume":"4","author":"Lee","year":"2018","journal-title":"Osteoporosis Sarcopenia"},{"issue":"7","key":"10.1016\/j.scr.2021.102239_b0365","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","article-title":"The pros and cons of mesenchymal stem cell-based therapies","volume":"28","author":"Musia\u0142-Wysocka","year":"2019","journal-title":"Cell Transplant"},{"key":"10.1016\/j.scr.2021.102239_b0370","first-page":"1","article-title":"COVID-19 and its therapeutics: special emphasis on mesenchymal stem cells based therapy","author":"Verma","year":"2020","journal-title":"Stem Rev. Rep."},{"key":"10.1016\/j.scr.2021.102239_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/9628536","article-title":"Challenges and controversies in human mesenchymal stem cell therapy","volume":"2","author":"Lukomska","year":"2019","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.scr.2021.102239_b0380","doi-asserted-by":"crossref","first-page":"17772","DOI":"10.1038\/s41598-020-74598-5","article-title":"Expression of SARS-CoV-2 entry factors in lung epithelial stem cells and its potential implications for COVID-19","volume":"10","author":"Valyaeva","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.scr.2021.102239_b0385","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.scr.2021.102239_b0390","article-title":"Nanoconjugates-based stem cell therapy for the management of COVID-19","author":"Desai","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.scr.2021.102239_b0395","unstructured":"Clinical Trials Gov, 2020. Available online: https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=covid-19+&term=msc&cntry=&state=&city=&dist=."},{"key":"10.1016\/j.scr.2021.102239_b0400","unstructured":"Clinical Trials Gov, 2020. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04288102 (23\/11\/2020)."},{"key":"10.1016\/j.scr.2021.102239_b0405","unstructured":"Clinical Trials Gov, 2020. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04355728 (23\/11\/2020)."},{"key":"10.1016\/j.scr.2021.102239_b0410","unstructured":"Clinical Trials Gov, 2020. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04492501 (23\/11\/2020)."},{"key":"10.1016\/j.scr.2021.102239_b0415","unstructured":"Clinical Trials Gov, 2020. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04276987 (23\/11\/2020)."},{"key":"10.1016\/j.scr.2021.102239_b0420","unstructured":"Clinical Trials Gov, 2020. Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04573270 (23\/11\/2020)."},{"issue":"13","key":"10.1016\/j.scr.2021.102239_b0425","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.scr.2021.102239_b0430","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2106\/JBJS.19.00266","article-title":"Direct to consumer advertising of stem cell clinics: Ethical considerations and recommendations for the healthcare community","volume":"101","author":"Pean","year":"2019","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.scr.2021.102239_b0435","unstructured":"Knoepfler, P., 2020. We Cannot Stick to the Rules: claims of stem cells saving COVID-19 patients. The Niche, March 3, 2020. https:\/\/ipscell.com\/2020\/03\/we-cannotstick-to-the-rules-claims-of-stem-cellssaving-covid-19-patients\/."},{"issue":"9","key":"10.1016\/j.scr.2021.102239_b0440","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/sctm.17-0282","article-title":"Concise Review: a comprehensive analysis of reported adverse events in patients receiving unproven stem cellbased interventions","volume":"7","author":"Bauer","year":"2018","journal-title":"Stem Cells Transl. Med."}],"container-title":["Stem Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506121000854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1873506121000854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:33:41Z","timestamp":1761737621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1873506121000854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":88,"alternative-id":["S1873506121000854"],"URL":"https:\/\/doi.org\/10.1016\/j.scr.2021.102239","relation":{},"ISSN":["1873-5061"],"issn-type":[{"value":"1873-5061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical progress: Stem cells as a new therapeutic strategy for COVID-19","name":"articletitle","label":"Article Title"},{"value":"Stem Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scr.2021.102239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102239"}}